309 related articles for article (PubMed ID: 34148364)
1. Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.
Ho JK; Moriarty F; Manly JJ; Larson EB; Evans DA; Rajan KB; Hudak EM; Hassan L; Liu E; Sato N; Hasebe N; Laurin D; Carmichael PH; Nation DA
Hypertension; 2021 Sep; 78(3):629-643. PubMed ID: 34148364
[TBL] [Abstract][Full Text] [Related]
2. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
Ashby EL; Kehoe PG
Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
[TBL] [Abstract][Full Text] [Related]
3. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
Weber MA
J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
[TBL] [Abstract][Full Text] [Related]
4. The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.
Sica DA
Curr Hypertens Rep; 2010 Apr; 12(2):67-73. PubMed ID: 20424943
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
7. Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study.
Demir M; Gürol AO; Özyiğit RT; Üresin AY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):538-43. PubMed ID: 26906033
[TBL] [Abstract][Full Text] [Related]
8. [Blockers of renin-angiotensin-aldosterone system in the treatment of arterial hypertension: classics versus the modern].
Kanorskiĭ SG
Kardiologiia; 2013; 53(10):89-95. PubMed ID: 24645559
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
10. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
Minami J; Ishimitsu T; Matsuoka H
Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
[No Abstract] [Full Text] [Related]
11. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
13. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of renin: an updated review of the development of renin inhibitors.
Li YC
Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
Nussberger J; Bohlender J
Nat Rev Cardiol; 2013 Apr; 10(4):183-4. PubMed ID: 23478259
[TBL] [Abstract][Full Text] [Related]
16. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
Shimosawa T
Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
[TBL] [Abstract][Full Text] [Related]
17. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
Nilsson PM; Cifkova R; Kjeldsen SE
J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123
[No Abstract] [Full Text] [Related]
18. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.
Contreras F; de la Parte MA; Cabrera J; Ospino N; Israili ZH; Velasco M
Am J Ther; 2003; 10(6):401-8. PubMed ID: 14624277
[TBL] [Abstract][Full Text] [Related]
19. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
20. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
